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The oral route of drug administration is the most popular 
and successfully used for conventional delivery of drugs. It 
offers the advantages of convenience, ease of 
administration, greater flexibility in dosage form design, 
ease of production, and low cost. The parenteral route of 
administration is important in case of emergencies, while 
the topical route of drug administration recently employed 
to deliver drug to the specific part of the body for systemic 
effect. It is probable that almost 90% of all the drugs are 
administered by oral route. Tablets are solid preparations 
each containing a single dose of one or more active 
substances and usually obtained by compressing uniform 
volumes of particles. Tablets are intended for oral 
administration. Some are swallowed whole, some after 
being chewed, some are dissolved or dispersed in water 
before being administered and some are retained in the 
mouth where the active substance is liberated. The 
particles consist of one or more active substances with or 
without excipients such as diluents, binders, disintegrating 
agents, glidants, lubricants, substances capable of 
modifying the behavior of the preparation in the digestive 
tract coloring matter authorized by the competent authority 
and flavoring substances.The dosage form available for 
oral administrations are solutions, suspensions,powders, 
tablets and capsules. The physical state of most of the 
drugs being solid,they are administered in solid dosage 
form. 
The drugs administered by oral route are versatile, flexible 
in dosage strength, relatively stable, present lesser problem 
in formulation and packaging and are convenient to 
manufacturer, store, handle and use. Solid dosage forms 
provide best protection to drugs against temperature, light, 
oxygen and stress during transportation. 
Advantages of tablets  
 They are unit dosage form, and they offer the 
capabilities of all oral dosage forms for the dose 
precision and the least content variability during 
dosing 
  Accuracy and uniformity of drug content 
 Optimal drug dissolution and hence, availability from 
the dosage form for absorption consistent with 
intended use (i.e., immediate or extended release). 
  Usually taken orally, but can be administered 
sublingually, rectally or intravaginally. 
 Their cost is lowest of all oral dosage forms 
 They are the most compact of all oral dosage forms 
  They are in general the easier and cheaper to package 
and ship as compare to other oral dosage forms 
 Product identification is simple and cheap, requiring 
no additional processing steps when employing an 
embossed or monogrammed punch face 
  They are ease to administer, does not require a 
specialist 
  They are better suited to large-scale production than 
other unit oral forms 
  They have the better properties of chemical, 




 Some drugs resist compression, due to their 
amorphous nature or low-density 
 Drugs having bitter taste, objectionable odor or drugs 
that are sensitive to oxygen may require encapsulation 
or coating of tablet 
 Bioavailability problems. 
 Chance of GI irritation caused by locally high 
concentrations medicament. 
 Difficulty in swallowing tablets in a small proportion 
of people and so size and shape become important 
considerations. 
 Slow onset of action as compared to parenterals and 
solutions 
 
Types and Classes of Tablets 
1-3 
Tablets are classified by their route of administration or 
functions 
1) Oral tablets for ingestion 
ABSTRACT: 
Olmesartan medoxomile  blocks  the  vasoconstrictor  and  aldosterone-secreting  effects  of  angiotensin  II  by  selectively  
binding  to  the  AT1 angiotensin  II  receptor.  ACE inhibitor is used  in treatment  of  hypertension. Olmesartan medoxomile 
tablet have been prepared  by  wet  granulation method and also by direct compression. Effect of various fillers and 
disintegrants  were also explored. Microcrystalline cellulose, lactose monohydrate, were used in wet granulation. In order to 
obtain acceptable product several  trials  were  conducted.And ten different formulations were prepared.  Various  
pharmacopoeial  evaluations  of  the  formulations  were  conducted  including  weight  variation,  hardness,  
disintegrationtime, friability  and in-vitro dissolution.  Final  selection of  formulation  was  done  based on pharmaceutical  
equivalence  of  development  formulation to  that  of marketed one. 
Keywords: Immediate release tablet, Superdisintegrants, lactose monohydrate, hypertension. 
Mayur et al                                Journal of Drug Delivery & Therapeutics; 2013, 3(2), 186-195   187 
© 2011, JDDT. All Rights Reserved                                                      ISSN: 2250-1177                                                     CODEN (USA): JDDTAO 
 Compressed tablets or standard compressed tablets 
  Multiple compressed tablets (MCT) 
a) Layered tablets 
b) Compression coated tablets 
 Repeat action tablets 
 Sustained release or modified release tablets 
 Delayed action or enteric-coated tablets 
 Film coated tablets 
 Chewable tablets 
2) Tablets used in oral cavity 
 Buccal tablets 
 Sublingual tablets 
 Troches and lozenges 
 Dental cones 
3) Tablets administered by other routes 
 Implantation tablets 
 Vaginal tablets 
4) Tablets used to prepare solutions 
  Effervescent tablets 
 Dispersible tablets 
 Hypodermic tablets 
  Tablet triturates 
 The pharmaceutical tablet dosage form 
Ideal properties of tablets and basic consideration 
4-6
 
Tablets are the most popular solid dosage forms used 
nowadays, due to ease of manufacture and administration 
for the patient. About two-thirds of all prescriptions are 
dispensed as solid dosage forms, and half of these are 
compressed tablets. Tablet drug delivery system can range 
from relatively simple immediate-release formulations to 
complex extended or modified-release dosage forms. A 
tablet is a mixture of active pharmaceutical ingredient 
(API) and excipients, usually in powder form, pressed or 
compacted into a solid. The excipients include binders, 
lubricants, glidants (flowaids), disintegrants, sweeteners or 
flavors and pigments. A coating may be applied to hide the 
taste of the tablet's components, to make the tablet 
smoother and easier to swallow, and to make it more 
resistant to the environment, extending its shelf life.Tablets 
are often stamped with symbols, letters, and numbers, 
which enable them to be identified. Size of tablet is from a 
few millimeters to centimeter. Some tablets are in the 
shape of capsules, and are called "caplets". Excipients are 
critical to the design of the delivery system and play a 
major role in determining its quality and performance. 
They may be selected to enhance stability (antioxidants, 
UV absorbers), optimize or modify drug release 
(disintegrants,hydrophilic polymers, wetting agents, 
biodegradable polymers), provide essential manufacturing 
technology functions (binders, glidants, lubricants), 
enhance patient acceptance (flavors), or aid in product 
identification (colorants). Thus a tablet formulation is not a 
random combination of ingredients, but rather a carefully 
throughout, rational formulation designed to satisfy the 
above criteria. The objectives of the design and 
manufacture of the compressed tablet is to deliver orally 
the correct amount of drug in the proper form, at or over 
the proper time and in the desired location. Beside the 
physical and chemical properties of medicinal agents 
formulated as a tablet, it should posses following 
characteristics. 
 Should be an elegant product having its own identity, 
while being free of defects such as chips, cracks, 
discoloration, contamination and the like 
 Should have the strength to withstand rigors of 
mechanical shocks encountered in its production, 
packaging, shipping and dispensing 
 Should have the chemical and physical stability to 
maintain its physical/chemical attributes over time 
 It must be able to release the medicinal agents in the 
body in a predictable and reproducible manner 
 Must have suitable chemical stability over a time so as 
not to allow alteration of the medicinal agents 
 Tablet Manufacturing 
7,8
 
The manufacturing of oral solid dosage forms such as 
tablets is a complex multi-stage process under which the 
starting materials change their physical characteristics a 
number of times before the final dosage form is produced. 
Traditionally, tablets have been made by granulation. Both 
wet granulation and dry granulation or direct compression 
is used. 
Following are the various unit processes which are 
involved in making tablets 
1. Dispensing 
2. Sizing 
3. Powder blending 
4. Granulation 
5. Drying 
6. Tablet compression 
7. Packaging 
Various factors associated with these processes can 
seriously affect content uniformity, bioavailability or 
stability. 
1. Dispensing (weighing and measuring) 
Dispensing is the first step in any pharmaceutical 
manufacturing process. It is one of the most critical steps 
in pharmaceutical manufacturing; as during this step, the 
weight of each ingredient in the mixture is determined 
according to dose. Dispensing may be done manually by 
hand scooping from primary containers and weighing each 
ingredient by hand on a weigh scale, manual weighing 
with material lifting assistance like vacuum transfer and 
bag lifters, manual or assisted transfer with automated 
weighing on weigh table, manual or assisted filling of loss-
in weight dispensing system, automated dispensaries with 
mechanical devices such as vacuum loading system and 
screw feed system. 
2. Sizing 
Sizing is a process in which the size of particle is changed 
to promote desired properties in a tablet. 
Advantages of sizing include: 
 Improved tablet-to-tablet content uniformity by virtue 
of increased number of particles per unit weight. 
 Controlled particle size distribution of dry granulation 
or mix to promote better flow of mixture in tablet 
machine. 
 Improved flow properties of raw materials. 
Mayur et al                                Journal of Drug Delivery & Therapeutics; 2013, 3(2), 186-195   188 
© 2011, JDDT. All Rights Reserved                                                      ISSN: 2250-1177                                                     CODEN (USA): JDDTAO 
 Improved color and/or active ingredient dispersion in 
tablet excipients. 
 Uniformly sized wet granulation to promote uniform 
drying. There are also certain disadvantages 
associated with this unit operation if not controlled 
properly. They are as follows: 
 A possible change in polymorphic form of the active 
ingredient, rendering it less or totally inactive, or 
unstable. 
 A decrease in bulk density of active compound and/or 
excipients, which may cause flow problem and 
segregation in the mix. 
 An increase in surface area from size reduction may 
promote the adsorption of air, which may inhibit 
wettability of the drug to the extent that it becomes the 
limiting factor in dissolution rate.  
A number of different types of machines may be used for 
dry sizing or milling depending on whether gentle 
screening or particle milling is needed. The ranges of 
equipment employed for this process includes Fluid energy 
mill, Colloidal mill, Ball mill, Hammer mill, Cutting mill, 
Roller mill, Conical mill, etc. 
3. Powder Blending 
The successful mixing of powder is acknowledged to be 
more difficult unit operation because, unlike the situation 
with liquid, perfect homogeneity is practically 
unattainable. In practice, problems also arise because of 
the inherent cohesiveness and resistance to movement 
between the individual particles. The process is further 
complicated in many systems, by the presence of 
substantial segregation influencing the powder mix. They 
arise because of differences in size, shape, surface 
morphology, density of the component particles etc. The 
powder/granules blending is involved at pre granulation 
and/or post granulation stage of tablet manufacturing. Each 
process of mixing has optimum mixing time and so 
prolonged mixing may result in an undesired product. So, 
the optimum mixing time and mixing speed are to be 
evaluated. Blending step prior to compression is normally 
achieved in a simple tumble blender. The blender may be a 




Granulation may be defined as a size enlargement process 
which converts small particles into physically stronger & 
larger agglomerates. The objective of granulation is to 
improve powder flow and handling, decrease dustiness, 
and prevent segregation of the constituents of the product. 
Granulation method can be broadly classified into two 
types: 
(i) Wet granulation and (ii) Dry granulation 
Ideal characteristics of granules 
The ideal characteristics of granules include spherical 
shape, smaller particle size distribution with sufficient 
fines to fill void spaces between granules, adequate 
moisture (between 1-2%), good flow, good compressibility 
and sufficient hardness. 
The effectiveness of granulation depends on the following 
properties: 
  Particle size of the drug and excipients 
  Type of binder (strong or weak) 
  Volume of binder (less or more) 
  Wet massing time (less or more) 
  Amount of shear applied 
  Drying rate (Hydrate formation and polymorphism) 
(i) Wet granulation  
Wet granulation is a commonly used unit operation in the 
pharmaceutical     industry. 
Wet granulation is often carried out utilizing a high-shear 
mixer. The high-shear granulation process is a rapid 
process which is susceptible for over-wetting. Thus, the 
liquid amount added is critical and the optimal amount is 
affected by the properties of the raw materials. Power 
consumption of the impeller motor and the impeller torque 
have been applied to monitor the rheological properties of 
the wet mass during agglomeration and, thereby, have 
been used to determine the end-point of water addition. 
However, these methods are affected by the equipment 
variables. Hence, additional process monitoring techniques 
would be valuable.  
 Important steps involved in wet granulation 
1. Mixing of drug(s) and excipients. 
2. Preparation of binder solution. 
3. Mixing of binder solution with powder mixture to form 
wet mass. 
4. Course screening of wet mass using a suitable sieve (6-
12 screens). 
5. Drying of moist granules. 
6. Screening of dry granules through a suitable sieve (14-
20 screen). 
7. Mixing of screened granules with disintegrant, glidant, 
and lubricant. 
 Limitation of wet granulation 
 The greatest disadvantage of wet granulation is its 
cost. It is an expensive process because of labor, time, 
equipment, energy and space requirements. 
  Loss of material during various stages of processing. 
  Stability may be a major concern for moisture 
sensitive or thermolabile drugs. 
 An inherent limitation of wet granulation is that any 
incompatibility between formulation components is 
aggravated. 
 Special wet granulation techniques: 
 High shear mixture granulation 
 Fluid bed granulation 
 Extrusion-spheronization 
 Spray drying 
(ii) Dry granulation 
 
In dry granulation process the powder mixture is 
compressed without the use of heat 
and solvent. The two basic procedures are to form a 
compact of material by compression and then to mill the 
compact to obtain granules. Two methods are used for dry 
granulation. The more widely used method is slugging, 
where the powder is precompressed and the resulting 
tablets or slugs are milled to yield granules. The other 
method is to precompress the powder with pressure rolls 
using a machine such as Chilosonator. 
 Advantages: 
The main advantages of dry granulation or slugging are 
that it uses less equipments and space. It eliminates the 
need for binder solution, heavy mixing equipment and the 
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costly and time consuming drying step required for wet 
granulation. Slugging can be used for advantages in the 
following situations: 
 For moisture sensitive material 
 For heat sensitive material 
  For improved disintegration since powder particles 
are not bonded together by a binder 
 Disadvantages: 
 It requires a specialized heavy duty tablet press to form 
slug. 
 It does not permit uniform color distribution as can be 
achieved with wet granulation where the dye can be 
incorporated into binder liquid. 
 The process tends to create more dust than wet 
granulation, increasing the potential contamination. 
Steps in dry granulation: 
1. Milling of drugs and excipients 
2. Mixing of milled powders 
3. Compression into large, hard tablets to make slug 
4. Screening of slugs 
5. Mixing with lubricant and disintegrating agent 
6. Tablet compression 
Two main dry granulation processes: 
 a. Slugging process 
Granulation by slugging is the process of compressing dry 
powder of tablet formulation with tablet press having die 
cavity large enough in diameter to fill quickly. The 
accuracy or condition of slug is not too important. Only 
sufficient pressure to compact the powder into uniform 
slugs should be used. Once slugs are produced they are 
reduced to appropriate granule size for final compression 
by screening and milling. 
b. Roller compaction 
The compaction of powder by means of pressure roll can 
also be accomplished by a machine called Chilosonator. 
Unlike tablet machine, the Chilosonator turns out a 
compacted mass in a steady continuous flow. The powder 
is fed down between the rollers from the hopper which 
contains a spiral auger to feed the powder into the 
compaction zone. Like slugs, the aggregates are screened 
or milled for production into granules. 
(iii) Direct compression 
3, 7 
The term “direct compression” is defined as the process by 
which tablets are compressed directly from powder 
mixture of API and suitable excipients. No pretreatment of 
the powder blend by wet or dry granulation procedure is 
required. Amongst the techniques used to prepare tablets, 
direct compression is the most advanced technology. It 
involves only blending and compression, thus offering 
advantage particularly in terms of speedy production, as it 
requires fewer unit operations, less machinery, reduced 
number of personnel and considerably less processing time 
along with increased product stability. 
Advantages: 
 Direct compression is more efficient and economical 
process as compared to other processes, because it 
involves only dry blending and compaction of API 
and necessary excipients. 
 The most important advantage of direct compression 
is that it is an economical process. Reduced 
processing time, reduced labor costs, fewer 
manufacturing steps, and less number of equipments is 
required, less process validation, reduced consumption 
of power. 
 Elimination of heat and moisture, thus increasing not 
only the stability but also the suitability of the process 
for thermolabile and moisture sensitive API. 
 Particle size uniformity. 
 Prime particle dissolution. 
 In case of directly compressed tablets after 
disintegration, each primary drug particle is liberated. 
While in the case of tablets prepared by compression 
of granules, small drug particles with a larger surface 
area adhere together into larger agglomerates; thus 
decreasing the surface area available for dissolution. 
Disadvantages: 
Excipients Related 
 Problems in the uniform distribution of low dose 
drugs. 
 High dose drugs having high bulk volume, poor 
compressibility and poor flowability are not suitable 
for direct compression for example, Aluminum 
Hydroxide, Magnesium Hydroxide. 
 The choice of excipients for direct compression is 
extremely critical. Direct compression diluents and 
binders must possess both good compressibility and 
good flowability. 
 Many active ingredients are not compressible either in 
crystalline or amorphous forms. 
Process Related 
 Capping, lamination, splitting, or layering of tablets is 
sometimes related to air entrapment during direct 
compression. When air is trapped, the resulting tablets 
expand when the pressure of tablet is released, 
resulting in splits or layers in the tablet. 
 In some cases require greater sophistication in 
blending and compression equipments. 
 Direct compression equipments are expensive. 
2 List of advancement technique in Granulations  
 Steam Granulation 
 Melt Granulation / Thermoplastic Granulation 
 Moisture Activated Dry Granulation (MADG) 
 Moist Granulation Technique (MGT) 
 Thermal Adhesion Granulation Process (TAGP) 
  Foam Granulation 
5. Drying 
 
Drying is a mass transfer process resulting in the removal 
of water from a solid by evaporation. The essential 
constituents of an effective piece of drying equipment are 
heat supply to increase the temperature and thereby reduce 
relative humidity, a device for removal of evaporated 
water and a means of minimizing the distance that water 
molecules must diffuse before they can be evaporated. 
The fluidized bed drier is the most commonly used device 
for drying tablet granules. The solid is fluidized from 
below by a jet of hot air, and so each granule is separated 
from its neighboring granules. The air provides an 
effective means of heat transfer, as well as of removing 
water vapors. The speed of the drying process is governed 
by the distance that water molecules must diffuse before 
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they arrive at the evaporative surface. Since the wet 
granules are present as individual units, the maximum 
distance over which diffusion occurs is equal to the radius 
of a granule. Hence, fluidized bed drying is a rapid 
process.A more traditional means of drying is the tray 
drier. Hot air flows over a series of shelves on which the 
wet material is spread. Compared to the fluidized bed 
drier, the solid-air interface is smaller, and water 
molecules may have to diffuse through the whole thickness 
of the solid layer before the evaporative surface is reached. 
Thus, the drying process is slower in a tray drier than in a 
fluidized bed drier. 
6. Compression 
During compression (Figure 1.1), the bulk volume of the 
material is reduced, resulting in the displacement of the 
gaseous phase (air). Further increasing the force leads to 
particle deformation and rearrangement. At this point, the 
three principal modes of deformation are as follows: 
A. Elastic deformation: A spontaneously reversible 
deformation of the compact in which, upon removal of the 
load, the powder mass reverts back to its original form. 
Most materials undergo elastic deformation to some 
extent. Compression of rubber would be by elastic 
deformation. 
B. Plastic deformation: After exceeding the elastic limit 
of the material (yield point), the deformation may become 
plastic, that is, the particles undergo viscous flow. This is 
the predominant mechanism when the shear strength 
between the particles is less than the tensile or breaking 
strength. Plastic deformation is a time-dependent process. 
C. Brittle fracture: Upon exceeding the elastic limit of 
the material (yield point), the particles undergo brittle 
fracture if the shear strength between the particles is 
greater than the tensile or breaking strength. Under these 
conditions, the larger particles are sheared and broken into 
smaller particles. Since some of these deformation 
characteristics are time-dependent, machine characteristics 
can have a major effect on tableting performance. These 
characteristics determine the rate of force application, 
dwell time (i.e., the time of maximum compression force, 
which depends on the punch head flat diameter and the 
tangential velocity), and the rate of decompression.
 
 
Figure 1: Compression Process 
Problems in Tablet Manufacturing 
 
An ideal tablet should be free from any visual defect or 
functional defect. The advancements and innovations in 
tablet manufacture have not decreased the problems, often 
encountered in the production, instead have increased the 
problems, mainly because of the complexities of tablet 
presses; and/or the greater demands of quality. An 
industrial pharmacist usually encounters number of 
problems during manufacturing. Majority of visual defects 
are due to inadequate fines or inadequate moisture in the 
granules ready for compression or due to faulty machine 
setting. 
Functional defects are due to faulty formulation. Solving 
many of the manufacturing problems requires an in-depth 
knowledge of granulation processing and tablet presses, 
and is acquired only through an exhaustive study and a 
rich experience. 
Following are the defects that are found during tablet 
manufacturing 
 Capping 
 Lamination / Laminating 
 Chipping 
  Cracking 
  Sticking / Filming 
  Picking 
  Binding 
  Mottling 
 Double impression 
  
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Figure 2: Forces and Time Relationship 
 
 
Figure 3: Tablet Defects 
Evaluation parameter 
 
To design tablet and later monitor tablet production 
quality, quantitative evaluation and assessment of tablets 
chemical, physical and bioavailability properties needs to 
be evaluated by using following parameters. 
 General appearance 
 Unique identification marking 
 Organoleptic properties 
 Hardness and friability 
 Weight variation 
 Drug content 
 Disintegration time 
 Dissolution profile 
 Impurity profile 
 Ideal characteristics of excipients  
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 They must be non toxic with no pharmacological 
activity and acceptable to the regulatory agencies in 
the countries where the product is to be marketed 
 They must be commercially available in an acceptable 
grade in countries where the product is to be 
manufacture 
 Cost effective 
 They must be physiologically inert 
 They must be physically and chemically stable by 
themselves and in combination with other drugs and 
tablet components 
 They must be free of any unacceptable 
microbiological load 
 They must be color compatible, should not change 
shade of color in the formulation 
 If product is classified as food, the diluents and other 
excipients must be approved food additives 
 They must not have an adverse effect on the 
bioavailability of the products 
 
Introduction to Immediate Release Dosage Form : 
Pharmaceutical products designed for oral delivery and 
currently available on the prescription and over-the-
counter markets are mostly the immediate release type, 
which are designed for immediate release of drug for rapid 
absorption. Disintegrating agents are substances routinely 
included in tablet formulations and in some hard shell 
capsule formulations to promote moisture penetration and 
dispersion of the matrix of the dosage form in dissolution 
fluids. Superdisintegrant improve disintegrant efficiency 
resulting in decreased use levels when compared to 
traditional disintegrants. Traditionally, starch has been the 
disintegrant of choice in tablet formulation, and it is still 
widely used. For instance, starch generally has to be 
present at levels greater than 5% to adversely affect 
compatibility, especially in direct compression. Drug 
release from a solid dosage form can be enhanced by 
addition of suitable disintegrants. 
  Mechanism of Disintegrants: 
                 1) High swellability 
                 2) Capillary action and high swellability 
                 3) Chemical reaction 
When introduced to an aqueous environment of use, the 
tablet rapidly takes up water, leading to swelling of the 
disintegrant and rapid disintegration of the tablet before 
the dispersion polymer can form a hydrogel. The 
disintegrant should be chosen such that it (1) swells rapidly 
when introduced into the use environment and (2) has a 
low tendency to form or promote formation of a hydrogel. 
The rate of swelling of the disintegrant is directly 
correlated to tablet disintegration times. Tablets containing 
disintegrants cause more rapid swelling have faster 
disintegration times at comparable disintegrant levels. 
The amount of work, W, or swelling energy, due to 
swelling can be measured using a dynamic mechanical 
analyzer (DMA). The swelling energy attributable to 
swelling of the disintegrant in the compact may be 
calculated from the following equation: 
W=P∆V 
Where W is the work or swelling energy of the 
disintegrant, P is the pressure applied by the probe, and ∆V 
is the volume change of the sample. 
To compare disintegrants, the swelling energy per mass of 
disintegrant is used. Preferably, the disintegrant generates 
a swelling energy of at least 0.05 J/g within about 10 
minutes following addition of water to the liquid reservoir. 
The most popular disintegrants are corn starch, soluble 
starch etc. which have been well dried and powdered. 
Starches have great affinity for water and swell when 
moistened thus facilitating the rupture of the tablet matrix, 
its disintegration action in tablets is due to capillary action. 
Spherical shape of starch increases the porosity of tablet 
thus promoting capillary action. 
Classification of “Superdisintegrant” may be organized 
into three classes based on their chemical structure. As 
shown in Table below. 
 
Table 1: List of Disintegrants 
Disintegrants Concentration in granules (%w/w) Special comments 
Starch USP 5-20 Higher amount is required, poorly compressible 
Starch 1500 5-15 - 
Avicel®(PH 101, PH 102) 10-20 Lubricant properties and directly compressible 
Solka floc® 5-15 Purified wood cellulose 
Alginic acid 1-5 Acts by swelling 
Na alginate 2.5-10 Acts by swelling 
Explotab® 2-8 Sodium starch glycolate, superdisintegrant. 
Polyplasdone®(XL) 0.5-5 Cross-linked PVP 
Amberlite® (IPR 88) 0.5-5 Ion exchange resin 





 1-3 Direct compression 
2-4 Wet granulation 
 
 Incorporation into Immediate Release Dosage 
Forms  
The immediate release dosage form comprises the 
dispersion, a porosigen, and a disintegrant. The dosage 
form is in the form of a compressed tablet or other solid 
dosage form. Other conventional formulation excipients 
may be employed in the dosage forms including 
surfactants, pH modifiers, fillers, matrix materials, 
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complexing agents, solubilizers, pigments, lubricants, 
glidants, flavorants, may be used for customary purposes 
and in typical amounts without adversely affecting the 
properties of the compositions. 
 Solid Dispersion: 
The dosage forms contain a high loading of the solid 
amorphous dispersion. High loadings of dispersion in the 
dosage form minimize the size of the dosage form, making 
it easier for the patient to swallow it and improving patient 
compliance. Depending on the drug dose, the immediate 
release dosage form comprises at least 30-50 wt % of the 
dispersion. 
This type of dosage forms disintegrates within 10 minutes 
following introduction to a disintegration medium. The 
dosage form of the present invention releases at least 70 wt 
%, more preferably at least 80 wt % and most preferably at 
least 90 wt % of the low solubility drug within 35 minutes 
following introduction to a dissolution medium. 
 Concentration-Enhancing Polymers: 
Concentration enhancing polymers suitable for use in the 
solid drug dispersions in the sense that they do not 
chemically react with the drug in an adverse manner. The 
polymer can be neutral or ionizable, and should have an 
aqueous solubility of at least 0.1 mg/mL over at least a 
portion of the pH range of 1-8. 
It is preferred that the concentration-enhancing polymer be 
"amphiphilic" in nature, meaning that the polymer has 
hydrophobic and hydrophilic portions. It is believed that 
such polymers have relatively strong interactions with the 
drug and may promote the formation of various types of 
polymer/drug assemblies in solution. 
A particularly preferred class of amphiphilic polymers is 
those that are ionizable noncellulosic polymers. Exemplary 
polymers include: carboxylic acid-functionalized vinyl 
polymers, such as the carboxylic acid-functionalized 
polymethacrylates and polyacrylates such as the Eudragit; 
amine-functionalized polyacrylates and polymethacrylates; 
proteins, such as gelatin and albumin; and carboxylic 
acidfunctionalized starches such as starch glycolate. 
Another class of polymers suitable for use comprises non-
ionizable or neutral non-cellulosic polymers. Exemplary 
polymers include: vinyl polymers and copolymers having 
at least one substituent selected from the group consisting 
of hydroxyl, alkylacyloxy, and cyclicamido; polyvinyl 
alcohols; polyvinyl alcohol polyvinyl acetate copolymers; 
polyvinyl pyrrolidone; polyethylene polyvinyl alcohol 
copolymers. 
The amount of concentration-enhancing polymer relative 
to the amount of drug present in the solid drug dispersions 
depends on the drug and concentration-enhancing polymer 
and may vary widely from a drug-to-polymer weight ratio 
of 0.01 to 5, or from about 1 to about 80 wt % drugs. 
However, in most cases, except when the drug dose is 
quite low, i.e., 25 mg or less, it is preferred that the drug-
to-polymer ratio is greater than 0.05 and less than 2.5. The 
maximum drug: polymer ratio that yields satisfactory 
results varies from drug to drug and is best determined in 
the in vitro and/or in vivo dissolution tests. 
 Preparation of Dispersions: 
Different methods are also been used for preparation of 
solid dispersions such as Melting method, Solvent method, 
Melting solvent method (melt evaporation), Melt extrusion 
method, Lyophilisation Technique, Melt Agglomeration 
Process, The Use Of Surfactant, Electrospinning and Super 
Critical Fluid Technology. 
 Disintegrants: 
As disintegrants sodium starch glycolate(SSG), sodium 
carboxymethyl cellulose, calcium carboxymethyl 
cellulose, croscarmellose sodium, Crospovidone, polyvinyl 
polypyrrolidone, methyl cellulose, microcrystalline 
cellulose, powdered cellulose, lower alkyl-substituted 
hydroxypropyl cellulose, polacrilin potassium, starch, 
pregelatinized starch, sodium alginate, and mixtures 
thereof. The amount of disintegrant included in the dosage 
form will depend on several factors, including the 
properties of the dispersion, the properties of the porosigen 
and the properties of the disintegrant selected. Generally, 
the disintegrant will comprise from 1 wt % to 25 wt % of 
the dosage form. 
  Porosigen: 
The dosage form also includes a porosigen. A "porosigen" 
is a material that, when present in the formulation 
containing the solid amorphous dispersion, leads to a high 
porosity and high strength following compression of the 
blend into a tablet. In addition, preferred porosigen are 
soluble in an acidic environment with aqueous solubility 
typically greater than 1 mg/mL at a pH less than about 5. 
Examples of porosigens include acacia, calcium carbonate, 
calcium sulfate, calcium sulfate dihydrate, compressible 
sugar, dibasic calcium phosphate, tribasic calcium 
phosphate, monobasic sodium phosphate, dibasic sodium 
phosphate, lactose, magnesium oxide, magnesium 
carbonate, silicon dioxide, magnesium aluminum silicate, 
maltodextrin, mannitol, methyl cellulose, microcrystalline 
cellulose, sorbitol, sucrose, xylitol and mixtures thereof. 
Generally, the porosigen will comprise from 5 to 70 wt %. 
To ensure the tablet has sufficient porosity to allow 
adequate wicking of water into the tablet to cause rapid 
tablet disintegration and/or rapid release of drug, tablet 
porosity should be within 0.15-0.25. Accordingly, the 
disintegrant and porosigen should be selected so that the 
immediate release dosage form has high strength as well as 
the high porosity required to achieve rapid disintegration 
and/or release of drug. 
 Surfactants: 
One very useful class of excipients is surfactants, 
preferably present from 0 to 10 wt %. Suitable surfactants 
include fatty acid and alkyl sulfonates; commercial 
surfactants such as benzalkonium chloride, dioctyl sodium 
sulfosuccinate, polyoxyethylene sorbitan fatty acid esters, 
natural surfactants such as sodium taurocholic acid, 
lecithin, and other phospholipids and mono- and 
diglycerides; and mixtures thereof. Such materials can 
advantageously be employed to increase the rate of 
dissolution by, for example, facilitating wetting, or 
otherwise increase the rate of drug release from the dosage 
form. 
  pH Modifiers: 
Inclusion of pH modifiers such as acids, bases, or buffers 
may also be beneficial in an amount of from 0 to 10 wt %. 
Acidic pH modifiers (e.g., acids such as citric acid or 
succinic acid) retard the dissolution of the pharmaceutical 
composition when the dispersion polymer is anionic. 
Alternatively, basic pH modifiers (e.g., sodium acetate or 
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amines) enhance the rate of dissolution of the same types 
of pharmaceutical composition. 
 Diluents: 
Examples of other matrix materials, fillers, or diluents 
include lactose, mannitol, xylitol, dextrose, sucrose, 
sorbitol, compressible sugar, microcrystalline cellulose, 
powdered cellulose, starch, pregelatinized starch, 
dextrates, dextran, dextrin, dextrose, maltodextrin, calcium 
carbonate, dibasic calcium phosphate, tribasic calcium 
phosphate, calcium sulfate, magnesium carbonate, 
magnesium oxide, poloxamers, polyethylene oxide, 
hydroxypropyl methyl cellulose and mixtures thereof. 
 Surface Active Agents: 
Sodium lauryl sulfate and polysorbate 80. Drug-
complexing agents or solubilizers include the polyethylene 
glycols, caffeine, xanthene, gentisic acid and cylodextrins. 
 Lubricants: 
Examples of lubricants include calcium stearate, glyceryl 
monostearate, glyceryl palmitostearate, hydrogenated 
vegetable oil, light mineral oil, magnesium stearate, 
mineral oil, polyethylene glycol, sodium benzoate, sodium 
lauryl sulfate, sodium stearyl fumarate, stearic acid, talc 
and zinc stearate. 
  Glidants: 
Examples of glidants include silicon dioxide, talc and 
cornstarch. Preferably from 10 to 50 wt % of the dosage 
form Tablets are generally formed by blending the 
dispersion, disintegrant, and porosigen with optional 
excipients and then compressing the powder to form 
tablets. Often it is desirable to granulate the compositions, 
with or without the addition of excipients prior to 
compression. For example, the dispersion, disintegrant, 
and porosigen may be granulated by mechanical means for 
example, roller compaction or "slugging," followed by 
milling to form granules. The granules typically have 
improved flow, handling, blending, and compression 
properties relative to the ungranulated materials. Wet 
granulation techniques may also be employed, provided 
the solvents and process selected do not alter the properties 
of the solid amorphous dispersion. Improved wetting, 
disintegrating, dispersing and dissolution properties may 
be obtained by the inclusion of other excipients. 
After the tablet is formed by compression, it is desired that 
the tablet has "strength" of at least 5-10 Kp/cm2. Here, 
"strength" is the fracture force, also known as the tablet 
"hardness," required to fracture a tablet formed from the 
materials. The fracture force may be measured using a 
Schleuniger Tablet Hardness Tester. Friability is a 
wellknown measure of a tablet's resistance to surface 
abrasion that measures weight loss in percentage after 
subjecting the tablets to a standardized agitation procedure. 
Friability values of from 0.8 to 1.0% are regarded as 
constituting the upper limit of acceptability.
 










S. No. INSTRUMENTS MANUFACTURER 
1. Electronic Weighing Balance Essae-Teraoka Ltd, Model No. 
IND/09/2001/28 
2. UV-Vis Spectrophotometer (UV-1800) Shimadzu, Japan. 
3. FTIR Spectrophotometer Shimadzu, Japan. 
4. Electronic Weighing Balance  Remi Equipments, Mumbai. 
5. Dissolution test apparatus TDT-08T ElectroLab, Mumbai. 
6. Digital vernier caliper Mitutoyo, Japan. 
7. Digital pH meter 7007 Digisun Electronics Hyderabad. 
8. Test Sieve (No.16, 22, 40, 60, 80) Scientific Engineering Corp. Delhi. 
9. Hot Air Oven Servewell Instrument PVT LTD, Bangalore. 
10. Stability Chamber Lab Control Equipment Co. Mumbai.  
11. Friabilator USP EF-2 ElectroLab, Mumbai. 
12. Monsanto Hardness Tester Ketan engineering Ltd, Mumbai 
13. Tablet punching machine, Rimek mini press-1 Karnavati Engineering Ltd, Mehsana, Gujarat. 
14. Melting Point Apparatus SETCO Ltd, Bangalore. 
 
S. NO. MATERIALS GRADE MANUFACTURER 
1. Olmesartan medoxomile A.R Purchased from Seva fine chem, Ahmedabad.                         
2. Micro crytalline cellulose L.R. Amneal pharmaceutical pvt  Ltd., Ahmedabad. 
3. Pregelatinized Starch L.R. Amneal pharmaceutical pvt  Ltd., Ahmedabad. 
4. Sodium Starch Glycolate L.R. Amneal pharmaceutical pvt  Ltd., Ahmedabad 
5. Lactose monohydrate L.R. S d fine-chem limited. Mumbai. 
6. Hydroxy propyl cellulose L.R. Amneal pharmaceutical pvt  Ltd.,  Ahmedabad. 
7. Magnesium Staerate L.R. Amneal pharmaceutical pvt  Ltd., Ahmedabad. 
8. Sodium stearyl fumarate L.R. Merck specialities private limited, Mumbai. 
9. Talc L.R Central drug house (P) Ltd., New Delhi. 
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Physico-mechanical characterization 
Bulk Density: 
It refers to packing of particles. Bulk density is used to 
determine the amount of drug that occupies the volume in 
g/ml. 
Procedure: Weighed quantity (10gm) of Drug X was 
transferred into 100 ml measuring cylinder without tapping 
during transfer. The volume occupied by drug was 
measured. Bulk density was measured by using formula 
                                                       ρi   = m /Vi 
                    Where, m   = mass of the blend 
             Vi   = untapped volume 
Tapped density:  
Weighed quantity (10gm) of drug was taken into a 
graduated cylinder. Volume occupied by the drug was 
noted down. Then the cylinder was subjected to 500, 750 
&1250 taps in tap density apparatus (Electro Lab USP II). 
According to USP, The blend was subjected for 500 taps. 
% Volume variation was calculated and subjected for 
additional 750 taps. % Variation is calculated. 
                                  ρt = m/Vt 
Where, Vt is tapped volume 
Carr’s Index (Compressibility):  
The compressibility index and Hausner ratio are measures 
of the property of powder to be compressed. The packing 
ability of drug was evaluated from change in volume, 
which is due to rearrangement of packing occurring during 
tapping. It was indicated as Carr’s compressibility index 
was calculated as follows. 
Carr’s index = [Tapped density - Bulk density/Tapped 
density] X 100 
Hausner Ratio: It is measurement of frictional resistance 
of the drug .The ideal range should be 1.2-1.5. It was 
determined by the ratio of tapped density and bulk density 
Hausner Ratio = Tapped density / Bulk density 
Angle of Repose: 
It is defined as the maximum angle that can be obtained 
between the free standing of powder heap and horizontal 
plane, which is given by the equation: 
                                                       = tan-1 h/r 
Where,     = Angle of repose. 
              h   = Height of powder heap.  
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